www.oxysure.com (OXYS)
OxySure Therapeutics Establishes Supply Agreement with ORS Nasco, a Division of Essendant
Frisco, Texas, February 4, 2016 - The Company has established a supply agreement with ORS Nasco, a division of Essendant, a global distributor of workplace essentials with $5.4 billion in sales.
"This agreement allows us to offer additional, complimentary offerings to our institutional customers seeking a single source solution for their medical emergency preparedness, therapeutics and medical risk management needs," stated Julian T. Ross, CEO of OxySure. "In addition to our OxySure Model 615 and related therapeutics and medical emergency offerings, our sales teams can now offer expanded solutions for first aid safety, respiratory protection, heat stress protection and eye protection, to name just a few options."
OxySure plans to develop a new, enhanced catalog of products which will be expanded to include first aid kits, antiseptics, CPR masks and eye wash solutions in the first aid safety category; disposable and escape respirators in the respiratory protection category; and hydration and cooling solutions in the heat stress protection category.
Read More:
http://finance.yahoo.com/news/oxysure-therapeutics-oxys-establishes-supply-130000167.html
Oxysure has now evolved into a complete Therapeutic Solutions company, offering a wide array of products for everyday emergency, and crisis intervention.
We believe it is at most advantageous price for new entries and a great average out down position. A Diamond in the Rough LONG PLAY, with Short Term Gain potential.
Robert E. Kreh
Principal
Small Cap Solutions, LLC
(443) 567-2609
robkreh@smallcapsolutions.com
robkreh@gmail.com
Disclaimer: You are receiving this message because you have recently requested it and/or in the past expressed an interest in or about information and updates concerning the company OxySure, Therapeutics, Inc., and/or other Micro/Small Cap Companies. This profile has been compiled by Small Cap Solutions, LLC based on information believed to be true. This profile is not guaranteed, neither implied, nor in writing, as to the accuracy and completeness of content, and has been prepared for information purposes only. As such, this profile may contain forward reaching statements, as defined in the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from the statements either expressed or implied herein. Prospective investors are advised to review the Company's periodic filings with the Securities and Exchange Commission or at yahoofinance.com or otcmarkets.com Small Cap Solutions, LLC has received cash or Rule 144 Restricted Shares (39,175) from OxySure Therapeutics, Inc. for investor relations services rendered. Small Cap Solutions, LLC has no intentions to actively trade any shares at this point in time. Additional inquiries available by email to admin@smallcapsolutions.com or by mail to 303 Joppa Crossing Ct. (Suite#1) Joppa, Md. 21085. To unsubscribe to this mailing list, please reply "unsubscribe" to this message.
Disclaimer: All Micro/Small Cap Company(ies) profile(s) are/have been compiled by Small Cap Solutions, LLC based on information believed to be true and gathered either from client companies and/or third party('s)/web sites. These profiles are not guaranteed, neither implied, nor in writing, as to the accuracy and completeness of content, and has been prepared for information purposes only. As such, this profile may contain forward reaching statements, as defined in the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from the statements either expressed or implied herein. Prospective investors are advised to review the Company's periodic filings with the Securities and Exchange Commission or at yahoofinance.com or otcmarkets.com Small Cap Solutions, LLC may receive cash or stock from client companies for investor relations services rendered. Small Cap Solutions, LLC and/or its Principal/Employees are not registered Broker(s)/Broker Dealer(s) with FINRA or the SEC. Small Cap Solutions, LLC does not make any buy/sell recommendations at any time, but may state their opinion on companies, etc. That is not meant to be a recommendation. All information disseminated by Small Cap Solutions, LLC is believed to be true and public. Additional inquiries available by email to admin@smallcapsolutions.com or by mail to 303 Joppa Crossing Ct. (Suite#1) Joppa, Md. 21085. To unsubscribe to this mailing list, please reply "unsubscribe" to this message.